Edition:
United Kingdom

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.47USD
7:32pm GMT
Change (% chg)

$-0.17 (-3.66%)
Prev Close
$4.64
Open
$4.69
Day's High
$4.77
Day's Low
$4.44
Volume
262,262
Avg. Vol
417,900
52-wk High
$8.37
52-wk Low
$4.33

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Rogers

57 2017 Chairman of the Board

Gregory Madison

49 2015 Chief Executive Officer, Director

Scott Holmes

42 2015 Chief Financial Officer, Treasurer

Christine Carberry

56 2017 Chief Operating Officer

Douglas Jermasek

2016 Vice President of Marketing and Strategy